Essais cliniques sur Hyperlipoprotéinémie de type 5 - Registre des essais cliniques

NCT00325455

Interrompue

MK0859 Dose-Ranging Study (0859-003)

Conditions: Hypercholesterolemia; Mixed Hyperlipemia
NCT00473655

Terminé

Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

Conditions: Hypertriglyceridemia; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemia Type IIb; Hyperlipidemia
NCT02069106

Retirée

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Conditions: Mixed Hyperlipoproteinemia
NCT01974297

Statut inconnu

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

Conditions: Mixed Hyperlipidemia
NCT00289900

Terminé

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Conditions: Mixed Hyperlipidemia
NCT00134238

Interrompue

Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.

Conditions: Mixed Hyperlipidemia
NCT00941603

Terminé

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Conditions: Primary Hypercholesterolemia; Mixed Hyperlipidemia
NCT00269217

Terminé

Lipid Efficacy Study (0524B-022)(COMPLETED)

Conditions: Primary Hypercholesterolemia; Mixed Hyperlipidemia
NCT00269204

Terminé

Lipid Efficacy/Tolerability Study (0524A-020)

Conditions: Primary Hypercholesterolaemia; Mixed Hyperlipidaemia